(EU) enCore Energy Common Shares - NASDAQ

Sector: Energy | Industry: Uranium | Exchange: NASDAQ (USA) | Market Cap: 268m USD | Total Return: -43.6% in 12m

Uranium, Nuclear Fuel, Mineral Resources
Total Rating 6
Safety 23
Buy Signal -1.49
Uranium
Industry Rotation: -24.3
Market Cap: 268M
Avg Turnover: 3.84M
Risk 3d forecast
Volatility85.2%
VaR 5th Pctl14.0%
VaR vs Median-0.38%
Reward TTM
Sharpe Ratio-0.41
Rel. Str. IBD1.9
Rel. Str. Peer Group1.5
Character TTM
Beta2.637
Beta Downside3.157
Hurst Exponent0.488
Drawdowns 3y
Max DD76.52%
CAGR/Max DD-0.27
CAGR/Mean DD-0.66

Warnings

Interest Coverage Ratio -6.3 is critical

Below Avwap Earnings

Tailwinds

No distinct edge detected

Description: EU enCore Energy Common Shares

enCore Energy Corp. (EU) is a Dallas-based uranium developer focused on the acquisition and extraction of uranium resources within the United States. The company utilizes In-Situ Recovery (ISR) technology, a method that extracts uranium through groundwater circulation rather than traditional open-pit mining. This approach typically results in lower capital expenditures and a smaller environmental footprint compared to conventional mining operations.

The uranium sector is currently supported by a global shift toward nuclear energy as a source of carbon-free baseload power. As a domestic producer, enCore Energy is positioned to benefit from U.S. initiatives aimed at reducing reliance on foreign nuclear fuel supplies. For a deeper analysis of these industry tailwinds and company-specific metrics, consider reviewing the latest data on ValueRay.

Classified as a small-cap entity within the energy sector, the company has been publicly traded since 2014. Its primary business model centers on advancing its portfolio of South Texas and Wyoming assets toward production to meet increasing demand from the utility sector.

Headlines to Watch Out For
  • Uranium spot price volatility dictates revenue and asset valuation
  • In-situ recovery production ramp-up at South Texas processing plants
  • Domestic nuclear fuel demand increases following Russian uranium import ban
  • Strategic uranium sales contracts provide long-term cash flow stability
Piotroski VR-10 (Strict) 1.0
Net Income: -27.2m TTM > 0 and > 6% of Revenue
FCF/TA: -0.13 > 0.02 and ΔFCF/TA -0.03 > 1.0
NWC/Revenue: 281.1% < 20% (prev 77.26%; Δ 203.8% < -1%)
CFO/TA -0.09 > 3% & CFO -38.7m > Net Income -27.2m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 11.08 > 1.5 & < 3
Outstanding Shares: last quarter (191.4m) vs 12m ago 2.79% < -2%
Gross Margin: 22.33% > 18% (prev -21.77%; Δ 44.10% > 0.5%)
Asset Turnover: 10.61% > 50% (prev 12.74%; Δ -2.12% > 0%)
Interest Coverage Ratio: -6.33 > 6 (EBIT TTM -30.8m / Interest Expense TTM 4.86m)
Altman Z'' 1.37
A: 0.27 (Total Current Assets 133.5m - Total Current Liabilities 12.1m) / Total Assets 451.7m
B: -0.45 (Retained Earnings -202.3m / Total Assets 451.7m)
C: -0.08 (EBIT TTM -30.8m / Avg Total Assets 407.1m)
D: 1.49 (Book Value of Equity 254.8m / Total Liabilities 170.5m)
Altman-Z'' = 1.37 = BB
What is the price of EU shares?

As of June 10, 2026, the stock is trading at USD 1.28 with a total of 2,981,656 shares traded.
Over the past week, the price has changed by -26.44%, over one month by -23.35%, over three months by -34.69% and over the past year by -43.61%.

Is EU a buy, sell or hold?

enCore Energy Common Shares has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy EU.

  • StrongBuy: 4
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the EU price?
Analysts Target Price 3.8 195.3%
enCore Energy Common Shares (EU) - Fundamental Data Overview as of 08 June 2026
Market Cap USD = 268.0m (268.0m USD * 1.0 USD.USD)
P/E Forward = 10.929
P/S = 6.2022
P/B = 1.2083
Revenue TTM = 43.2m USD
EBIT TTM = -30.8m USD
EBITDA TTM = -20.3m USD
Long Term Debt = 110.2m USD (from longTermDebt, last quarter)
Short Term Debt = 628k USD (from shortTermDebt, last quarter)
Debt = 116.9m USD (from shortLongTermDebtTotal, last quarter) + Leases 3.32m
Net Debt = 5.18m USD (calculated: Debt 116.9m - CCE 111.7m)
Enterprise Value = 273.2m USD (268.0m + Debt 116.9m - CCE 111.7m)
Interest Coverage Ratio = -6.33 (Ebit TTM -30.8m / Interest Expense TTM 4.86m)
EV/FCF = -4.82x (Enterprise Value 273.2m / FCF TTM -56.7m)
FCF Yield = -20.76% (FCF TTM -56.7m / Enterprise Value 273.2m)
 FCF Margin = -131.2% (FCF TTM -56.7m / Revenue TTM 43.2m)
 Net Margin = -62.96% (Net Income TTM -27.2m / Revenue TTM 43.2m)
Gross Margin = 22.33% ((Revenue TTM 43.2m - Cost of Revenue TTM 33.6m) / Revenue TTM)
Gross Margin QoQ = -0.35% (prev 37.92%)
Tobins Q-Ratio = 0.60 (Enterprise Value 273.2m / Total Assets 451.7m)
Interest Expense / Debt = 4.16% (Interest Expense 4.86m / Debt 116.9m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -24.3m (EBIT -30.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 11.08 (Total Current Assets 133.5m / Total Current Liabilities 12.1m)
Debt / Equity = 0.46 (Debt 116.9m / totalStockholderEquity, last quarter 254.8m)
 Debt / EBITDA = -0.25 (negative EBITDA) (Net Debt 5.18m / EBITDA -20.3m)
 Debt / FCF = -0.09 (negative FCF - burning cash) (Net Debt 5.18m / FCF TTM -56.7m)
 Total Stockholder Equity = 249.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -6.68% (Net Income -27.2m / Total Assets 451.7m)
RoE = -10.91% (Net Income TTM -27.2m / Total Stockholder Equity 249.3m)
RoCE = -8.56% (EBIT -30.8m / Capital Employed (Equity 249.3m + L.T.Debt 110.2m))
 RoIC = -5.55% (negative operating profit) (NOPAT -24.3m / Invested Capital 438.1m)
 WACC = 11.54% (E(268.0m)/V(384.9m) * Re(15.14%) + D(116.9m)/V(384.9m) * Rd(4.16%) * (1-Tc(0.21)))
Discount Rate = 15.14% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 82.22 | Cagr: 8.15%
 [DCF] Fair Price = unknown (Cash Flow -56.7m)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: -4.0 | # QB: -2
Revenue Correlation: 87.26 | Revenue CAGR: 63.51% | SUE: 1.50 | # QB: 1
EPS current Quarter (2026-06-30): EPS=-0.14 | Chg30d=-66.27% | Revisions=-20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=-0.11 | Chg30d=+11.29% | Revisions=+20% | Analysts=1
EPS current Year (2026-12-31): EPS=-0.36 | Chg30d=+9.13% | Revisions=+20% | GrowthEPS=+0.0% | GrowthRev=+65.1%
EPS next Year (2027-12-31): EPS=-0.31 | Chg30d=+22.25% | Revisions=-20% | GrowthEPS=+14.4% | GrowthRev=+27.7%
[Analyst] Revisions Ratio: -20%